Insulet (PODD) Change in Receivables (2010 - 2026)
Insulet's (PODD) quarterly Change in Receivables came in at $46.3 million in Q2 2026, up 217.12% on a YoY basis from $14.6 million in Q2 2025, and up 51.31% quarter-over-quarter from $30.6 million in Q1 2026.
Analysis
Insulet (PODD) Change in Receivables (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Change in Receivables for 15 consecutive years, with $46.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Receivables rose 217.12% year-over-year to $46.3 million; the trailing twelve-month figure through Jun 2026 stood at $288.3 million (up 873.99% YoY), and the FY2025 full-year result was $253.2 million, up 1398.22% from the prior year.
- Change in Receivables rose to $46.3 million in Q2 2026 per PODD's latest filing, from $30.6 million in the prior quarter.
- Across five years, Change in Receivables topped out at $209.8 million in Q4 2025 and bottomed at -$15.4 million in Q4 2022.
- Historically, Change in Receivables has averaged $25.5 million across 5 years, with a median of $16.9 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables sank 178.57% in 2022, then jumped 5927.78% in 2025.
- Over 5 years, Change in Receivables stood at -$15.4 million in 2022, then surged by 407.14% to $47.3 million in 2023, then sank by 107.61% to -$3.6 million in 2024, then surged by 5927.78% to $209.8 million in 2025, then sank by 77.93% to $46.3 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $46.3 million, $30.6 million, and $209.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 46.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.30 Mn |
| Mar 31, 2026 | 30.60 Mn |
| Dec 31, 2025 | 209.80 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 14.60 Mn |
| Mar 31, 2025 | 27.20 Mn |
| Dec 31, 2024 | -3.60 Mn |
| Sep 30, 2024 | -8.60 Mn |
| Jun 30, 2024 | 32.60 Mn |
| Mar 31, 2024 | -3.50 Mn |
| Dec 31, 2023 | 47.30 Mn |
| Sep 30, 2023 | 25.00 Mn |
| Jun 30, 2023 | 7.90 Mn |
| Mar 31, 2023 | 19.20 Mn |
| Dec 31, 2022 | -15.40 Mn |
| Sep 30, 2022 | 3.60 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 19.90 Mn |
| Dec 31, 2021 | 19.60 Mn |
| Sep 30, 2021 | 1.30 Mn |